首页|期刊导航|中南民族大学学报(自然科学版)|POX染色、EBV DNA和EBV IgA抗体在鼻咽癌筛查与诱导化疗前后的对比

POX染色、EBV DNA和EBV IgA抗体在鼻咽癌筛查与诱导化疗前后的对比OA

Comparison of POX staining,EBV DNA and EBV IgA antibodies in nasopharyngeal carcinoma screening and before-and-after induction chemotherapy

中文摘要英文摘要

[目的]评价鼻咽黏膜细胞POX染色、血浆EBV DNA及血清EBV IgA抗体在鼻咽癌筛查中的单项及联合诊断价值,分析不同临床症状与各指标阳性率的关系,并比较鼻咽癌患者诱导化疗前后各指标的变化.[方法]前瞻性纳入2022年9月至2025年1月就诊于广州医科大学附属第二医院耳鼻咽喉科的鼻咽肿物患者67例.所有受试者均行综合评估包括POX染色、EBV DNA、EBV IgA抗体检测及鼻咽肿物组织活检,根据病理结果分为鼻咽癌组(38例)和非鼻咽癌组(29例).比较两组在筛查阶段各指标单项及三项联合检测的诊断效能;记录鼻咽癌组颈部肿块、鼻塞、回吸血痰、血涕等临床症状,分析症状与检测结果的相关性;对鼻咽癌组诱导化疗前后的检测结果进行配对比较.对计量资料进行正态性检验(Shapiro-Wilk检验),符合正态分布的计量资料以"均数±标准差"表示,非正态分布的计量资料以"中位数(IQR)"表示;非正态分布计量资料的组间比较采用Mann-Whitney U检验.计数资料以"例数(%)"表示,组间比较采用Pearson Chi-Square检验、Continuity Correction检验或Fisher确切概率法,配对数据的比较采用McNemar检验;P<0.05为差异具有统计学意义.所有数据分析均使用IBM SPSS Statistics 25及GraphPad Prism 9软件完成.[结果]筛查阶段,鼻咽癌组POX染色、EBV DNA、EBV IgA阳性率分别为81.6%、34.2%、71.1%,均高于非鼻咽癌组(除EBV DNA外,其余指标P<0.05).三项联合检测灵敏度为89.5%,高于任一单项检测;特异度为31.0%,低于任一单项检测.不同临床症状患者各指标阳性率差异均无统计学意义(P>0.05).诱导化疗后,鼻咽癌组POX染色、EBV DNA、EBV IgA阳性率分别降至28.9%、0.0%、36.8%(均P<0.05).[结论]鼻咽黏膜细胞POX染色、血浆EBV DNA及血清EBV IgA抗体联合检测可显著提高鼻咽癌筛查灵敏度;各指标阳性率与临床症状无明显相关性.诱导化疗可显著降低三项指标阳性率,其有望作为近期疗效评价的客观指标.

[Objective]To evaluate the individual and combined diagnostic value of nasopharyngeal mucosal cell POX staining,plasma EBV DNA,and serum EBV IgA antibody for nasopharyngeal carcinoma(NPC)screening,to investigate the relationship between different clinical symptoms and positive detection rates of each indicator,and to compare the changes of each indicator in NPC patients before and after induction chemotherapy.[Methods]A total of 67 patients presenting with nasopharyngeal masses who were treated in the Department of Otorhinolaryngology,the Second Affiliated Hospital of Guangzhou Medical University from September 2022 to January 2025 were prospectively enrolled.All subjects underwent comprehensive evaluation including:POX staining,EBV DNA detection,EBV IgA antibody detection,and nasopharyngeal mass biopsy.According to the pathological results,they were divided into the NPC group(38 cases)and the non-NPC group(29 cases).The diagnostic efficacy of individual detection and their combination of the three indicators during the screening stage was compared between two groups.Clinical symptoms,including neck mass,nasal congestion,regurgitated blood-stained sputum,and bloody nasal discharge,were recorded in the NPC group,and their correlation with detection results was analyzed.For NPC group,the detection results before and after induction chemotherapy were compared in pairs.Normality test(Shapiro-Wilk test)was performed on the measurement data.Data following a normal distribution were presented as"mean±standard deviation",while non-normally distributed data were expressed as"median(IQR)".The Mann-Whitney U test was employed for comparison of non-normally distributed data.Count data were expressed as"cases(%)",and group comparisons was performed using Pearson Chi-Square test,Continuity Correction test,or Fisher ′s exact probability method.Paired categorical data comparison was performed using McNemar test.A P value<0.05 was considered statistically significant.All data analyses were performed using IBM SPSS Statistics 25 and GraphPad Prism 9 software.[Results]During the screening stage,the positive rates of POX staining,EBV DNA,and EBV IgA in the NPC group were 81.6%,34.2%,and 71.1%respectively,which were all higher than those in the non-NPC group(for all indicators except EBV DNA,P<0.05).The sensitivity of the combined detection of the three indicators was 89.5%,which was higher than that of any individual detections;the specificity was 31.0%,which was lower than that of any individual detection.There was no statistically significant difference in the positive rates of each indicator among patients with different clinical symptoms(P>0.05).After induction chemotherapy,the positive rates of POX staining,EBV DNA,and EBV IgA in the NPC group decreased to 28.9%,0.0%,and 36.8%,respectively(all P<0.05).[Conclusion]The combined detection of nasopharyngeal mucosal cell POX staining,plasma EBV DNA,and serum EBV IgA antibody can significantly improve the sensitivity of NPC screening;there is no obvious correlation between the positive rates of each indicator and clinical symptoms.Induction chemotherapy can significantly reduce the positive rates of the three indicators,which is expected to be used as an objective indicator for evaluating short-term therapeutic efficacy.

禤政文;陈芷颖;江烨;田慎之

广州医科大学附属第二医院 耳鼻咽喉科,广东 广州 510000广州医科大学附属第一医院 呼吸健康研究院,广东 广州 510000广州医科大学附属第二医院 耳鼻咽喉科,广东 广州 510000广州医科大学附属第二医院 耳鼻咽喉科,广东 广州 510000

医药卫生

鼻咽癌POX染色EB病毒DNAEB病毒IgA抗体早期筛查联合检测

nasopharyngeal carcinomaPOX stainingEpstein-Barr virus DNAEpstein-Barr virus IgA antibodyearly screeningcombined testing

《中南民族大学学报(自然科学版)》 2026 (5)

595-604,10

广东省医学科研基金资助项目(c2020081)

10.20056/j.cnki.ZNMDZK.20260723

评论